Theratechnologies (TH) to Release Quarterly Earnings on Wednesday

Theratechnologies (TSE:TH - Get Free Report) will be announcing its earnings results before the market opens on Wednesday, April 10th.

Theratechnologies (TSE:TH - Get Free Report) last posted its quarterly earnings results on Wednesday, February 21st. The company reported C($0.11) EPS for the quarter. Theratechnologies had a negative return on equity of 1,116.86% and a negative net margin of 29.30%. The business had revenue of C$31.93 million during the quarter.

Theratechnologies Price Performance

TSE TH traded down C$0.12 during trading hours on Thursday, reaching C$2.06. The company's stock had a trading volume of 7,973 shares, compared to its average volume of 41,964. The firm's 50-day moving average price is C$2.03 and its 200-day moving average price is C$2.16. The company has a quick ratio of 0.64, a current ratio of 1.34 and a debt-to-equity ratio of 562.07. Theratechnologies has a 1 year low of C$1.22 and a 1 year high of C$5.84. The company has a market capitalization of C$94.72 million, a price-to-earnings ratio of -1.75, a PEG ratio of -8.50 and a beta of 1.73.

Analyst Ratings Changes

Separately, Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Theratechnologies in a research report on Friday, January 12th.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients.